Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort Studies

By afschroeder • April 4, 2026

Cescon E, Goodwin P, Bobrie A, Thezenas S, Ganz T, Nemeth E, Lohmann A, Ennis M, Jacot W, Jerzak KJ. Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort Studies. Clin Breast Cancer. 2026 Apr 2;26(5):29-35. doi: 10.1016/j.clbc.2026.03.004. Epub ahead of print. PMID: 41932199.

Tags: biomarkers, breast neoplasms, Inflammation, iron metabolism, Obesity, Publications, Pulmonary, Critical Care & Sleep Medicine

Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer: a cost-effectiveness analysis

Padula WV, Cohen BG, Steel P, Appukkuttan S, Kalayeh B, Rettig M. Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer:[...]

Alpha-1 Antitrypsin PiMZ Heterozygosity in the Setting of Alcohol-Associated Cirrhosis: A Case Report

Ather N, Mwengela D, Blakey J. Alpha-1 Antitrypsin PiMZ Heterozygosity in the Setting of Alcohol-Associated Cirrhosis: A Case Report. Cureus. 2026 Sep 6;18(9):e115864. doi: 10.7759/cureus.115864.[...]

Triple M Overlap Syndrome: A Rare Complication of Immune Checkpoint Inhibitors

Morris B. Triple M Overlap Syndrome: A Rare Complication of Immune Checkpoint Inhibitors. Cureus. 2026 Sep 6;18(9):e115859. doi: 10.7759/cureus.115859. PMID: 42841091; PMCID: PMC13641304.